시장보고서
상품코드
1778333

세계의 동물 인공수정 시장 : 솔루션별, 동물 유형별, 최종사용자별, 지역별 - 기회 및 예측(2018-2032년)

Global Veterinary Artificial Insemination Market Assessment, By Solutions, By Animal Type, By End-user, By Region, Opportunities and Forecast, 2018-2032F

발행일: | 리서치사: Markets & Data | 페이지 정보: 영문 225 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계 동물 인공수정 시장 규모는 2025-2032년의 예측 기간 동안 6.53%의 연평균 복합 성장률(CAGR)로 2024년 69억 6,000만 달러에서 2032년 115억 4,000만 달러로 확대될 것으로 예측됩니다. 동물의 효율성과 생산성, 육류 소비, 우유 및 유제품에 대한 수요 증가, 지속 가능한 식량 생산에 대한 요구, 업계 이해 관계자의 노력에 대한 지원, 유성 정액 사용 증가 등이 동물 인공수정 시장을 주도하고 있습니다.

세계 동물용 인공수정(AI) 시장은 가축의 생산성 향상과 번식 효율성 향상에 대한 수요로 인해 빠르게 성장하고 있습니다. 인공수정은 수의학적 번식에서 중요한 역할을 하고 있으며, 통제된 환경에서의 유전적 선택, 질병 전염 감소, 가축의 번식력 강화 등 여러 가지 이점을 제공합니다. 인공수정은 번식 절차로서 농부나 브리더가 유전과 관련된 표적 형질을 획득하고, 우군의 품질을 개선하며, 가축의 번식 주기를 단축할 수 있게 해줍니다. 이는 결국 우유와 육류 등 세계 축산의 중요한 성장 분야를 뒷받침하게 될 것입니다. 이 시장을 뒷받침하는 것은 정액 처리, 정액에 사용되는 저장 및 전달 시스템, 그리고 유성 정액 및 배아 수송과 같은 기술 혁신입니다. 이러한 발전으로 인공수정은 점점 더 구체적이고, 이용 가능하고, 효율적이며, 특히 소, 돼지, 기타 가축 종 등 다양한 종에 대한 개선이 이루어지고 있습니다. 동물의 건강과 선택적 번식의 이점에 대한 지식 증가도 선진국과 개발도상국에서의 채택에 도움이 되고 있습니다.

기술의 가용성과 사용 측면에서 북미가 앞서 있습니다. 그럼에도 불구하고 아시아태평양과 라틴아메리카의 신흥 경제 국가들은 정부의 지원 정책, 축산 인구 증가, 농업 현대화라는 세 가지 주요 촉진요인에 의해 빠르게 발전하고 있습니다. 민간 수의사 서비스, 번식농장, 협동조합이 기술을 이용할 수 있게 되면서 접근성이 개선되고 시장 개척이 가능해졌습니다. 연구 개발에 대한 지속적인 투자와 수의학 및 광범위한 업계 내 협력으로 접근성이 향상되고, 솔루션의 가용성이 확대되며, 동물 인공수정 접근성과 결과를 개선하기 위한 시장 논의가 전 세계적으로 확대될 것으로 예측됩니다.

예를 들어, 2024년 1월 인도 국립낙농개발위원회(National Dairy Development Board)의 자회사인 Mother Dairy, India는 Gir, Kankrej 등 인도 토종 젖소의 인공수정을 통해 우유 생산량을 늘리기 위해 브라질에서 4 만회 분량의 황소 정액을 수입했습니다.

세계의 동물용 인공수정 시장에 대해 조사했으며, 시장 개요와 함께 솔루션별/동물 유형별/최종사용자별/지역별 동향, 시장 진출 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 프로젝트의 범위와 정의

제2장 조사 방법

제3장 미국 관세의 영향

제4장 주요 요약

제5장 세계의 동물 인공수정 시장 전망, 2018년-2032년

  • 시장 규모 분석과 예측
  • 시장 점유율 분석과 예측
    • 솔루션별
      • 기기 및 소모품
      • 정액
      • 서비스
    • 동물 유형별
      • 돼지
      • 양 및 산양
      • 기타
    • 최종사용자별
      • 동물 병원
      • 동물 클리닉
      • 동물 브리딩 센터
      • 기타
    • 지역별
      • 북미
      • 유럽
      • 아시아태평양
      • 남미
      • 중동 및 아프리카
    • 기업별 시장 점유율 분석(주요 5개사 및 기타-금액별, 2024년)
  • 2024년 시장 맵 분석

제6장 북미의 동물 인공수정 시장 전망, 2018년-2032년

  • 시장 규모 분석과 예측
  • 시장 점유율 분석과 예측
  • 국가별 시장 평가
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 동물 인공수정 시장 전망, 2018년-2032년

  • 독일
  • 프랑스
  • 이탈리아
  • 영국
  • 러시아
  • 네덜란드
  • 스페인
  • 튀르키예
  • 폴란드

제8장 아시아태평양의 동물 인공수정 시장 전망, 2018년-2032년

  • 인도
  • 중국
  • 일본
  • 호주
  • 베트남
  • 한국
  • 인도네시아
  • 필리핀

제9장 남미의 동물 인공수정 시장 전망, 2018년-2032년

  • 브라질
  • 아르헨티나

제10장 중동 및 아프리카의 동물 인공수정 시장 전망, 2018년-2032년

  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 남아프리카공화국

제11장 수급 분석

제12장 수출입 분석

제13장 밸류체인 분석

제14장 Porter의 Five Forces 분석

제15장 PESTLE 분석

제16장 가격 분석

제17장 시장 역학

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제

제18장 시장 동향과 발전

제19장 규제 프레임워크

  • 규제기관 승인

제20장 사례 연구

제21장 경쟁 구도

  • 시장 리더 주요 5개사의 경쟁 매트릭스
  • 참여 기업 주요 5개사의 SWOT 분석
  • 시장 주요 기업 10개사의 상황
    • Genus PLC
    • URUS GROUP LP
    • Cooperatie Koninklijke CRV u.a(CRV)
    • Semex Alliance
    • IMV Technologies
    • Select Sires, Inc.
    • Swine Genetics International
    • Shipley Swine Genetics
    • Stallion AI Services Ltd
    • Inguran Sorting Technologies LLP

제22장 전략적 제안

제23장 회사 소개 및 면책조항

LSH 25.08.01

Global veterinary artificial insemination market is projected to witness a CAGR of 6.53% during the forecast period 2025-2032, growing from USD 6.96 billion in 2024 to USD 11.54 billion in 2032. Increasing demand for animal efficiency and productivity, as well as demand for meat consumption, milk, and dairy products, along with requirements for sustainable food production, support for initiatives by industry stakeholders, and the increased use of sexed semen, drive the veterinary artificial insemination market.

The global veterinary artificial insemination (AI) market is developing rapidly, primarily driven by demand for increased livestock productivity and enhanced breeding efficiency. Artificial insemination plays a crucial role in veterinary reproduction, offering numerous advantages, including genetic selection in controlled environments, reduced disease transmission, and enhanced fertility in animals. As a reproductive procedure, AI enables farmers and breeders to acquire targeted traits involving genetics, improve herd quality, and reduce breeding cycles in livestock. In turn, supporting a crucial growing sector in worldwide animal products, such as milk and meat. The market is supported by technological breakthroughs in semen processing, the storage and delivery systems used in semen, and innovations such as sexed semen and embryo transport. These advancements have enabled artificial insemination to become increasingly specific, available, and efficient, with improvements for varied species, particularly cattle, swine, and other livestock species. Increased knowledge of animal health and the benefits of selective breeding are also helping adoption in regions that are either developed or in the process of development.

North America is ahead in terms of technology availability and use. Still, emerging economies in the Asia-Pacific and Latin America are developing rapidly due to three key driving factors: supportive government policies, an increase in livestock populations, and the modernization of their agriculture. The availability of technology by private veterinary services, breeding farms, and cooperative societies continued to improve access and grow market development. Continued investment in research and development, as well as cooperation within the veterinary and broader industry, is expected to advance accessibility, broaden solution availability, and expand the market discussion to improve access and outcomes of veterinary artificial insemination globally.

For instance, in January 2024, the National Dairy Development Board's subsidiary company, Mother Dairy, India, imported 40,000 doses of bull semen from Brazil to enhance milk production through artificial insemination of Indian native breeds, such as Gir and Kankrej.

Rising Demand for Genetic Improvement in Livestock Increased Market Share

The rising need to improve livestock genetics directly leads to the expanding veterinary artificial insemination market share. The agricultural sector, including farmers and breeders, dedicates itself to herd improvement through selective breeding to enhance productivity, health and profitability. The technique of artificial insemination provides precise methods to obtain superior genetics from top-performing sires, enabling genetic improvement across various locations. Livestock producers who implement AI technology achieve faster genetic improvements of milk yield, alongside growth rate, disease resistance, fertility, and overall animal quality. The enhanced profitability of farms, along with the benefits of food security through higher production rates without herd expansion, represents the outcome of this approach. Through genetic outcome control and disease transmission reduction, artificial insemination becomes more attractive to users. The commercialization and performance-driven nature of the livestock industry drives rising demand for AI-based genetic improvement, which expands its market growth worldwide.

For instance, in March 2024, the Press Information Bureau of India (PIB), an agency of the Indian Government, launched the Bharat Pashudhan Livestock Data Stack. This digital database enables real-time tracking and monitoring of livestock animals in the country by assigning each animal a unique ID number. By using this system, farmers can access information, upload veterinary-related data about artificial inseminations, vaccinations, new animal registrations, changes in animal ownership, diagnostic and treatment information for animal diseases, and record milk production, among other things. The PIB also noted that as of March 2024, 1.6 million entries per day are being added to this data stack.

Technological Advancements in Reproductive Solutions Fuel Market Growth

The veterinary artificial insemination market has been significantly influenced by advancements in reproductive technology. Developments in sexed semen, estrus synchronization protocols, hormone protocols, and embryo transfer procedures have improved the chances of success and precision with artificial insemination methods. This technology enables improved planning of breeding cycles, increased conception rates, and enhanced control over the sex and genetic quality of offspring. Automated insemination devices, combined with semen analyzers and portable ultrasound tools, have simplified the AI process by enhancing efficiency and reducing manual operator requirements. The new developments deliver essential value to large-scale commercial farming operations by improving productivity while maintaining high animal welfare standards. Digital tools, combined with farm management software, enable real-time monitoring of animal health and reproductive performance, generating data-driven decision-making capabilities. The veterinary AI market is experiencing rapid growth because technological solutions are becoming more affordable and accessible in both developed and developing regions.

For instance, in March 2025, the Indian government launched a sex-sorted semen program to produce female calves at the rate of 90%, to keep a consistent supply of high-yielding cows in Rajasthan, India. The state has received 1 lakh doses of sex-sorted semen, which will be produced in collaboration with NDDB in Rajasthan.

Bovine Animals Hold the Largest Global Veterinary Artificial Insemination Market Share

Bovine animals hold the largest market share in the veterinary artificial insemination (AI) market because they lead global dairy and meat production. The widespread adoption of AI in bovine breeding has been driven by the need for increased milk production, improved reproductive efficiency, and enhanced herd genetics. Artificial insemination enables breeders to utilize high-quality sires, allowing for faster genetic improvement, disease suppression, and increased productivity. In dairy farming, there is always a demand for cows that produce large quantities of milk, and AI has become an essential part of herd management. New technologies, such as sexed semen and estrus synchronization, facilitate suitable reproduction of bovines. The strength of traditional government programs, agricultural cooperatives, and veterinary service providers lends support and viability to AI in production units and farm settings alike. Bovine animals exhibit better manageability during artificial insemination procedures compared to smaller livestock, which strengthens their position as market leaders. Bovine animals maintain their strong position in the veterinary AI market because global demand for dairy and beef continues to increase.

For instance, in January 2023, BullWise, a breeding organization in Ireland, partnered with CRV to market CRV's genetic solutions in Ireland & Northern Ireland. This allowed farmers to access quality semen from top bulls. With this partnership, BullWise became an essential distributor for CRV in the region.

North America Dominates the Veterinary Artificial Insemination Market Size

North America holds a dominant position in the global veterinary artificial insemination market due to the presence of mature livestock production systems, established veterinary infrastructure and the widespread implementation of modern breeding technologies. The region also benefits from a great deal of awareness among farmers and breeders related to the benefits of artificial insemination, such as trait-based genetic improvement, disease management, and increased productivity. The region achieves extensive adoption of AI techniques because veterinary service providers collaborate with breeding cooperatives and agricultural support programs. The market expansion receives additional momentum from advanced tools, including sexed semen and automated insemination devices, together with genomic selection technology. Research institutions, in collaboration with private companies, dedicate resources to developing innovative reproductive solutions that are both efficient and cost-effective. Herd quality improvement and dairy and meat production enhancement receive vital support from government policies and industry initiatives, which also contribute significantly to the growth of the veterinary artificial insemination market. The North American veterinary AI market maintains its global leadership position due to its advanced technology and well-organized agricultural framework.

For instance, in August 2023, Urus Group, a premier participant in the genetics space, acquired Leachman Cattle of Colorado. This should establish URUS in a leadership position within the North American and global beef industries. This new partnership enables Urus to offer members and customers worldwide a significantly broader portfolio of genetic solutions. Leachman will continue to provide semen sales, bulls, females, and data services to beef operations in both the U.S. and international markets.

Impact of U.S. Tariffs on Global Veterinary Artificial Insemination Market

The implementation of U.S. tariffs has raised costs and disrupted supply chains throughout the veterinary artificial insemination market by imposing tariffs on equipment, semen materials, and veterinary supplies. Veterinary drugs are exempt from tariffs, but essential inputs, such as gloves and syringes, and active pharmaceutical ingredients face increased tariff costs, which drive up operational expenses for AI providers. The increased operational expenses impact all AI providers regardless of practice size, which forces them to consider raising service prices and face supply delays of vital materials. Stakeholders respond by dedicating funds to domestic manufacturing and research operations, which aim to decrease their import dependence while strengthening supply chain stability. The market continues to grow because innovative AI protocols and digital technologies advance despite tariff-related obstacles. Veterinary AI providers face two significant challenges from tariffs: short-term inflationary pressures and supply uncertainties, which affect their ability to sustain efficient breeding programs and genetic improvement efforts in livestock.

Key Players Landscape and Outlook

The competitive landscape of the veterinary artificial insemination market is characterized by the actions of companies that pursue innovation, form strategic partnerships, and expand their geographical presence. Continued investment in more labor-efficient reproductive technologies, such as sexed semen, genomic selection, and automated insemination technologies, will continue to drive growth. Companies are expanding their global footprint by developing both distribution and entering emerging markets, in addition to acquiring regional companies. Companies continue to invest in employee training and veterinary services to support on-the-ground implementation. With demand for efficient breeding solutions being heightened, the outlook remains bright, and the players will continue to diversify their offerings and use digital technologies to strengthen market presence and customer engagement.

In January 2025, IMV Technologies announced that Conception Ro-Main Inc., a Canadian leader in high-tech swine production solutions, joined its Farm Animal business. The acquisition is expected to be finalized in the first quarter of 2025. It immediately enhances IMV's global offering with Conception Ro-Main's AI-powered technologies and IoT solutions, leading to greater innovation in sustainable pig farming.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Veterinary Artificial Insemination Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Solutions
      • 5.2.1.1. Equipment and Consumables
      • 5.2.1.2. Semen
      • 5.2.1.3. Services
    • 5.2.2. By Animal Type
      • 5.2.2.1. Bovine
      • 5.2.2.2. Swine
      • 5.2.2.3. Ovine and Caprine
      • 5.2.2.4. Equine
      • 5.2.2.5. Others
    • 5.2.3. By End-user
      • 5.2.3.1. Animal Hospitals
      • 5.2.3.2. Animal Clinics
      • 5.2.3.3. Animal Breeding Centers
      • 5.2.3.4. Others
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia-Pacific
      • 5.2.4.4. South America
      • 5.2.4.5. Middle East and Africa
    • 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Solutions
    • 5.3.2. By Animal Type
    • 5.3.3. By End-user
    • 5.3.4. By Region

6. North America Veterinary Artificial Insemination Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Solutions
      • 6.2.1.1. Equipment and Consumables
      • 6.2.1.2. Semen
      • 6.2.1.3. Services
    • 6.2.2. By Animal Type
      • 6.2.2.1. Bovine
      • 6.2.2.2. Swine
      • 6.2.2.3. Ovine and Caprine
      • 6.2.2.4. Equine
      • 6.2.2.5. Others
    • 6.2.3. By End-user
      • 6.2.3.1. Animal Hospitals
      • 6.2.3.2. Animal Clinics
      • 6.2.3.3. Animal Breeding Centers
      • 6.2.3.4. Others
    • 6.2.4. By Country Share
      • 6.2.4.1. United States
      • 6.2.4.2. Canada
      • 6.2.4.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Veterinary Artificial Insemination Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Solutions
          • 6.3.1.2.1.1. Equipment and Consumables
          • 6.3.1.2.1.2. Semen
          • 6.3.1.2.1.3. Services
        • 6.3.1.2.2. By Animal Type
          • 6.3.1.2.2.1. Bovine
          • 6.3.1.2.2.2. Swine
          • 6.3.1.2.2.3. Ovine and Caprine
          • 6.3.1.2.2.4. Equine
          • 6.3.1.2.2.5. Others
        • 6.3.1.2.3. By End-user
          • 6.3.1.2.3.1. Animal Hospitals
          • 6.3.1.2.3.2. Animal Clinics
          • 6.3.1.2.3.3. Animal Breeding Centers
          • 6.3.1.2.3.4. Others
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Veterinary Artificial Insemination Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Veterinary Artificial Insemination Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Veterinary Artificial Insemination Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Veterinary Artificial Insemination Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

  • 17.1. Market Drivers
  • 17.2. Market Challenges

18. Market Trends and Developments

19. Regulatory Framework

  • 19.1. Regulatory Approvals

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Genus PLC
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. URUS GROUP LP
    • 21.3.3. Cooperatie Koninklijke CRV u.a (CRV)
    • 21.3.4. Semex Alliance
    • 21.3.5. IMV Technologies
    • 21.3.6. Select Sires, Inc.
    • 21.3.7. Swine Genetics International
    • 21.3.8. Shipley Swine Genetics
    • 21.3.9. Stallion AI Services Ltd
    • 21.3.10. Inguran Sorting Technologies LLP

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제